Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00854139 · ClinicalTrials.gov registry record · Phase 1
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00854139: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00854139 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00854139, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The primary objective is to cure multiple myeloma with less toxic allogeneic bone marrow transplantation while inducing renal allograft tolerance through mixed chimerism in patients with end stage renal failure and multiple myeloma
Interventions
- PROCEDURE Kidney transplant
- DRUG Cyclophosphamide, anti-thymocyte globulin
- RADIATION Thymic irradiation
- PROCEDURE Bone marrow transplant from a related donor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2001-08 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00854139
The ClinicalTrials.gov registry entry for NCT00854139 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Kidney transplant is the first listed.
NCT00854139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00854139 about?
NCT00854139 is a clinical study titled "Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)". The primary objective is to cure multiple myeloma with less toxic allogeneic bone marrow transplantation while inducing renal allograft tolerance through mixed chimerism in patients with end stage renal failure and multiple myeloma
What is the current status of trial NCT00854139?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2001-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00854139?
The interventions under investigation include: Kidney transplant (PROCEDURE), Cyclophosphamide, anti-thymocyte globulin (DRUG), Thymic irradiation (RADIATION), Bone marrow transplant from a related donor (PROCEDURE).
Who is sponsoring clinical trial NCT00854139?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.